Add BrightSurf on Google Email

Most historical cases of mass mortality caused by highly pathogenic avian flu had little or only short-term impacts on bird population size, per RSPB study analyzing past outbreaks

A study analyzing past outbreaks found most historical cases of mass mortality caused by highly pathogenic avian flu had minimal long-term effects on bird populations. The research suggests that the outbreaks may have had no significant impact on bird population size over time.

SourcePLOS·JournalPLOS One·DateNov 11, 2026

Avian influenza spread beyond a backyard coop on an Illinois farm, analysis finds

An Illinois farmer's backyard flock was nearly wiped out by highly pathogenic avian influenza virus, which also infected a domestic cat and wild rats. The viruses found in the animals were nearly identical, indicating a shared source and suggesting that mammalian-adaptation markers may be present in bird viruses.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalEmerging Infectious Diseases·TypeCase study·DateNov 5, 2026

Gas inside us could fight wound infections, moth study shows

A new study published in the Journal of Drug Delivery Science and Technology found that nitric oxide particles helped nine in ten infected wax moth larvae survive bacterial infections. The particles, which release nitric oxide slowly over several hours, showed promise in reducing bacterial loads by 10,000 to 100,000 times.

SourceUniversity of Reading·JournalJournal of Drug Delivery Science and Technology·TypeExperimental study·DateNov 2, 2026

Half of long COVID patients see meaningful symptom improvement within three years

A prospective cohort study found that about half of people living with long COVID experienced a meaningful symptom improvement within three years. By three years, 50.1% of participants experienced a sustained symptom improvement, and 56.4% experienced substantial symptom reductions along with a good quality of life.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateNov 2, 2026

As the cold season nears, immunization of newborns against universal RSV could significantly reduce infant hospitalizations across Europe

A new report by ECDC suggests that universal RSV immunization of newborns could prevent up to 61% of RSV-related hospitalizations in the first two months of life. The strategy aims to reduce the burden on healthcare systems during the winter season, when RSV, influenza, and other respiratory infections are most prevalent.

National study finds decline in drug use-associated heart infections but growing share involve stimulants

Hospitalizations for drug use-associated heart infections have declined by 18% from 2020 to 2022, primarily due to a decrease in opioid cases. Stimulants, such as methamphetamine and cocaine, are increasingly involved in these infections, particularly in the Western US, highlighting the need for improved treatment options.

SourceUniversity of Colorado Anschutz·JournalClinical Infectious Diseases·DateOct 27, 2026

New architecture for antifungal drug precisely combats fungal infections in mice without the usual toxicity

Researchers have created a new antifungal drug, mandimycin M16, which selectively targets fungal ergosterol without disrupting human cholesterol. This breakthrough could lead to safer and more effective treatments for fungal infections, including multidrug-resistant strains.

SourceAmerican Association for the Advancement of Science (AAAS)·JournalScience Translational Medicine·DateOct 21, 2026

Two-in-one tool tracks viral RNA inside live infected cells in real time

A team of researchers from Penn State has developed a fluorescent molecular tag that tracks viral RNA and host interactions in real-time, allowing for the study of Zika and chikungunya viruses. The tool, called Mango-II, provides insight into the viral-host cell interaction, a key step to developing effective antiviral strategies.

SourcePenn State·JournalNature Communications·TypeImaging analysis·DateOct 21, 2026

Scientific triumph, equity failure: Faster, fairer COVID-19 vaccine roll-out could have saved millions of lives, UN University publication reveals

A new Policy Brief from the UN University Institute for Water, Environment and Health argues that an equity-focused global mechanism is needed to improve vaccine financing, production, and delivery. The publication estimates that delaying the global vaccine roll-out by 100 days could have saved over 8 million lives by the end of 2021.

Proposed changes to hepatitis B vaccination schedule could significantly increase infections, model suggests

A modeling study suggests that delayed or shared decision-making approaches to hepatitis B vaccination could lead to a 19-83% increase in chronic infections among US children. The current universal birth-dose strategy remains the most effective strategy for preventing childhood infections.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateOct 19, 2026

UC3M participates in a pioneering scientific project using AI to anticipate human behavior during epidemics

Researchers at UC3M and University de Zaragoza are developing AI-driven epidemiological models that can replicate human behavior during epidemics, incorporating socioeconomic factors and social determinants. The project aims to create more accurate models that can inform public health decisions and reduce existing inequalities.

SourceUniversidad Carlos III de Madrid·TypeComputational simulation/modeling·DateOct 15, 2026

Ebola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans

Researchers have found that a single dose of the licensed Ebola vaccine can induce T cell cross-reactivity against the Bundibugyo virus, a closely related but distinct virus. This cross-reactivity may provide a level of protection against severe disease, although more studies are needed to confirm its effectiveness.

SourceGerman Center for Infection Research·JournalThe Lancet Infectious Diseases·TypeExperimental study·DateOct 14, 2026

Unexpected discovery of new mechanism which helps deadly fungus Candida auris evade treatment

A team of researchers discovered that Candida auris creates multiple versions of its genome, including a gene called CRZ1, which helps the fungus evade antifungal treatment. This finding opens up new avenues for treating the deadly fungus, which has already been linked to high mortality rates and costly outbreaks.

SourceUniversity of Exeter·JournalNature Communications·TypeExperimental study·DateOct 13, 2026

Many hospitals still don’t do enough to prevent UTIs from catheters

A new study shows that hospitals still have far to go in implementing strategies to prevent catheter-associated urinary tract infections (CAUTIs), despite 20 years of effort. The study found that only 49% of general hospitals and 32% of VA hospitals have a system in place to remind doctors of a patient's catheter status, and that highe...

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeSurvey·DateOct 6, 2026

Even modest post-infection complications can make expanded vaccine coverage cost effective: New modelling

Researchers developed a system of mathematical equations to examine interactions between interventions and post-infection effects. The team found that even small post-infection costs could shift the optimal vaccine coverage to higher rates, even to elimination levels.

SourceUniversity of British Columbia·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateOct 5, 2026

How cells fight back after bacterial toxins break through

Researchers at Juntendo University discovered a lipid signaling pathway involving 12-HHT and BLT2 that promotes plasma membrane repair and protects cells from membrane-damaging insults. Cells with enhanced BLT2 signaling showed better survival rates, less membrane leakage, and improved mitochondrial health after toxin exposure.

SourceJuntendo University Research Promotion Center·JournalJournal of Cell Biology·TypeExperimental study·DateOct 5, 2026

Model traces C. diff spread in hospital oncology units

A new study models C. diff transmission in oncology units, revealing that asymptomatic colonized patients are the primary source of new infections. The model provides a clearer picture of C. diff transmission events and could help inform protocols to prevent future disease transmission.

SourceNorth Carolina State University·JournalInfection Control and Hospital Epidemiology·TypeComputational simulation/modeling·DateOct 5, 2026

A deadly fungus may not live to see the last of us

Researchers identified a mechanism to kill the fungal pathogen Aspergillus fumigatus, which causes severe respiratory infections with high mortality rates. The study found that a genetic modification allowed the echinocandin drug to kill the fungus, paving the way for more targeted attacks.

SourceVirginia Tech·JournalMolecular Biology of the Cell·DateOct 1, 2026

Mediterranean rockrose extract shows fungicidal activity against fungi that cause common skin infections

A polyphenol-rich extract from Cistus salviifolius has shown fungicidal activity against several dermatophytes, including Trichophyton rubrum and Microsporum canis. The extract reduced fungal load and tissue invasion in a reconstructed human epidermis model, preserving the epidermal barrier and decreasing inflammation.

SourceUniversidad Miguel Hernandez de Elche·JournalJournal of Ethnopharmacology·TypeExperimental study·DateSep 28, 2026

Preventive tuberculosis treatment wanes after one year in high-burden countries, but lasts for at least 8 to 13 years in low- and medium-burden countries

Researchers found strong initial protection from TB preventive treatment (TPT) in 24 countries, but long-term protection varied depending on TB disease burden. In high-burden settings, protection waned after just one year, while in low- and medium-burden settings, it lasted at least 8 and 13 years, respectively.

SourceBoston University School of Public Health·JournalThe Lancet Respiratory Medicine·TypeMeta-analysis·DateSep 22, 2026